Target intelligence / Profile preview

RNA, U6 small nuclear 933, pseudogene (RNU6-933P)

Target
RNU6-933P
Molecular classification
Pseudogene, long non-coding RNA (lncRNA family, snRNA-derived pseudogene)
01

Overview

RNU6-933P (RNA, U6 small nuclear 933, pseudogene) is a non-coding RNA pseudogene located on chromosome 11 ([Ensembl: ENSG00000207153][2]). It is derived from the highly conserved U6 small nuclear RNA gene, a critical component of the spliceosomal machinery required for pre-mRNA splicing[1][5]. Unlike the canonical U6 snRNA, RNU6-933P is a defective copy that does not encode a functional RNA and thus does not participate directly in spliceosome assembly or catalysis. Such pseudogenes are formed by retrotransposition or gene duplication events and typically accumulate mutations that render them non-functional[4][7]. While most pseudogenes were historically considered "junk DNA," emerging evidence suggests some may influence gene regulation or act as competitive endogenous RNAs, though this is not specifically described for RNU6-933P[4][6]. It does not serve as a receptor, enzyme, transporter, or transcription factor, and there is no current evidence for direct roles in disease, drug interactions, or utility as a biomarker. Overall, RNU6-933P is best classified as a genomic pseudogene from the U6 small nuclear RNA family, without known direct functional or therapeutic implications.

Other names
RNU6-933PU6-933P
02

Mechanism of action

None (no drugs target this molecule)

03

Biological functions

Possible minor roles in chromatin remodeling, miRNA sponging, or mRNA regulation, as have been observed in some pseudogenes, but no well-characterized function for RNU6-933P specifically
04

Disease associations

None directly established; pseudogenes have sometimes been linked to regulatory functions in cancer or gene expression, but there is no specific evidence for RNU6-933P

Beyond the preview

Go deeper on RNA, U6 small nuclear 933, pseudogene (RNU6-933P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 933, pseudogene (RNU6-933P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call